Catalyst Pharmaceuticals (CPRX) Raw Materials (2023 - 2026)

Catalyst Pharmaceuticals' Raw Materials history runs 4 years deep, the most recent figure standing at $16.9 million for Q1 2026.

• Quarterly Raw Materials rose 127.02% year-over-year to $16.9 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $16.9 million (up 127.02% YoY) and the FY2025 annual result came in at $17.1 million, up 162.92% from the prior year.
• Raw Materials was $16.9 million for Q1 2026 at Catalyst Pharmaceuticals, down from $17.1 million in the prior quarter.
• Across five years, Raw Materials topped out at $17.1 million in Q4 2025 and bottomed at $1.9 million in Q4 2023.
• A 4-year average of $8.9 million and a median of $6.9 million in 2024 frame the typical range for Raw Materials.
• Annual changes were most pronounced in 2024 — Raw Materials surged 241.26% — and 2025, when it decreased 7.34%.
• Catalyst Pharmaceuticals' Raw Materials stood at $1.9 million in 2023, then jumped by 241.26% to $6.5 million in 2024, then soared by 162.92% to $17.1 million in 2025, then retreated by 1.51% to $16.9 million in 2026.
• Business Quant data shows CPRX's Raw Materials at $16.9 million in Q1 2026, $17.1 million in Q4 2025, and $12.1 million in Q3 2025.